Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002533923 | SCV003478326 | uncertain significance | not provided | 2024-03-04 | criteria provided, single submitter | clinical testing | This sequence change replaces tyrosine, which is neutral and polar, with histidine, which is basic and polar, at codon 60 of the RHO protein (p.Tyr60His). This variant is present in population databases (rs771007146, gnomAD 0.01%). This missense change has been observed in individual(s) with retinitis pigmentosa (Invitae). ClinVar contains an entry for this variant (Variation ID: 625298). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt RHO protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ocular Genomics Institute, |
RCV000767357 | SCV000897928 | uncertain significance | Retinitis pigmentosa 4 | 2019-01-09 | no assertion criteria provided | research | |
Institute of Human Genetics, |
RCV004817984 | SCV005071505 | uncertain significance | Retinal dystrophy | 2022-01-01 | no assertion criteria provided | clinical testing |